These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 10568859

  • 21. Prevention of tolerance to the antinociceptive effects of systemic morphine by a selective cholecystokinin-B receptor antagonist in a rat model of peripheral neuropathy.
    Idänpään-Heikkilä JJ, Guilbaud G, Kayser V.
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1366-72. PubMed ID: 9316848
    [Abstract] [Full Text] [Related]

  • 22. Role of kappa and delta opioid receptors in mediating morphine-induced antinociception in morphine-tolerant infant rats.
    Stoller DC, Sim-Selley LJ, Smith FL.
    Brain Res; 2007 Apr 20; 1142():28-36. PubMed ID: 17300766
    [Abstract] [Full Text] [Related]

  • 23. Evidence for a peripheral component in the enhanced antinociceptive effect of a low dose of systemic morphine in rats with peripheral mononeuropathy.
    Kayser V, Lee SH, Guilbaud G.
    Neuroscience; 1995 Jan 20; 64(2):537-45. PubMed ID: 7700537
    [Abstract] [Full Text] [Related]

  • 24. MGM-9 [(E)-methyl 2-(3-ethyl-7a,12a-(epoxyethanoxy)-9-fluoro-1,2,3,4,6,7,12,12b-octahydro-8-methoxyindolo[2,3-a]quinolizin-2-yl)-3-methoxyacrylate], a derivative of the indole alkaloid mitragynine: a novel dual-acting mu- and kappa-opioid agonist with potent antinociceptive and weak rewarding effects in mice.
    Matsumoto K, Takayama H, Narita M, Nakamura A, Suzuki M, Suzuki T, Murayama T, Wongseripipatana S, Misawa K, Kitajima M, Tashima K, Horie S.
    Neuropharmacology; 2008 Aug 20; 55(2):154-65. PubMed ID: 18550129
    [Abstract] [Full Text] [Related]

  • 25. Receptor-selective antagonism of opioid antinociception in female versus male rats.
    Craft RM, Tseng AH, McNiel DM, Furness MS, Rice KC.
    Behav Pharmacol; 2001 Dec 20; 12(8):591-602. PubMed ID: 11856896
    [Abstract] [Full Text] [Related]

  • 26. Analgesic and antiinflammatory effects of two novel kappa-opioid peptides.
    Binder W, Machelska H, Mousa S, Schmitt T, Rivière PJ, Junien JL, Stein C, Schäfer M.
    Anesthesiology; 2001 Jun 20; 94(6):1034-44. PubMed ID: 11465595
    [Abstract] [Full Text] [Related]

  • 27. Involvement of substance P in the anti-inflammatory effects of the peripherally selective kappa-opioid asimadoline and the NK1 antagonist GR205171.
    Binder W, Scott C, Walker JS.
    Eur J Neurosci; 1999 Jun 20; 11(6):2065-72. PubMed ID: 10336675
    [Abstract] [Full Text] [Related]

  • 28. Selective opioid receptor agonists modulate mechanical allodynia in an animal model of neuropathic pain.
    Desmeules JA, Kayser V, Guilbaud G.
    Pain; 1993 Jun 20; 53(3):277-285. PubMed ID: 8394563
    [Abstract] [Full Text] [Related]

  • 29. Nociceptin/orphanin FQ blocks the antinociception induced by mu, kappa and delta opioid agonists on the cold water tail-flick test.
    Chen X, Geller EB, Adler MW.
    Eur J Pharmacol; 2007 Feb 14; 557(1):32-6. PubMed ID: 17173891
    [Abstract] [Full Text] [Related]

  • 30. The kappa opioid receptor agonist SA14867 has antinociceptive and weak sedative effects in models of acute and chronic pain.
    Tsukahara-Ohsumi Y, Tsuji F, Niwa M, Hata T, Narita M, Suzuki T, Sasano M, Aono H.
    Eur J Pharmacol; 2011 Dec 05; 671(1-3):53-60. PubMed ID: 21970808
    [Abstract] [Full Text] [Related]

  • 31. Analgesic activity of ZC88, a novel N-type voltage-dependent calcium channel blocker, and its modulation of morphine analgesia, tolerance and dependence.
    Meng G, Wu N, Zhang C, Su RB, Lu XQ, Liu Y, Yun LH, Zheng JQ, Li J.
    Eur J Pharmacol; 2008 May 31; 586(1-3):130-8. PubMed ID: 18374913
    [Abstract] [Full Text] [Related]

  • 32. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.
    Yamada H, Shimoyama N, Sora I, Uhl GR, Fukuda Y, Moriya H, Shimoyama M.
    Brain Res; 2006 Apr 14; 1083(1):61-9. PubMed ID: 16530171
    [Abstract] [Full Text] [Related]

  • 33. Antihyperalgesic, Antiallodynic, and Antinociceptive Effects of Cebranopadol, a Novel Potent Nociceptin/Orphanin FQ and Opioid Receptor Agonist, after Peripheral and Central Administration in Rodent Models of Neuropathic Pain.
    Tzschentke TM, Linz K, Frosch S, Christoph T.
    Pain Pract; 2017 Nov 14; 17(8):1032-1041. PubMed ID: 28112482
    [Abstract] [Full Text] [Related]

  • 34. Subcutaneous, intrathecal and periaqueductal grey administration of asimadoline and ICI-204448 reduces tactile allodynia in the rat.
    Caram-Salas NL, Reyes-García G, Bartoszyk GD, Araiza-Saldaña CI, Ambriz-Tututi M, Rocha-González HI, Arreola-Espino R, Cruz SL, Granados-Soto V.
    Eur J Pharmacol; 2007 Nov 14; 573(1-3):75-83. PubMed ID: 17643411
    [Abstract] [Full Text] [Related]

  • 35. The development of pain-related behaviour and opioid tolerance after neuropathy-inducing surgery and sham surgery.
    Christensen D, Kayser V.
    Pain; 2000 Dec 01; 88(3):231-238. PubMed ID: 11068110
    [Abstract] [Full Text] [Related]

  • 36. Antiallodynic Effects of Endomorphin-1 and Endomorphin-2 in the Spared Nerve Injury Model of Neuropathic Pain in Mice.
    Wang CL, Yang DJ, Yuan BY, Qiu TT.
    Anesth Analg; 2017 Dec 01; 125(6):2123-2133. PubMed ID: 28787346
    [Abstract] [Full Text] [Related]

  • 37. GR94839, a kappa-opioid agonist with limited access to the central nervous system, has antinociceptive activity.
    Rogers H, Birch PJ, Harrison SM, Palmer E, Manchee GR, Judd DB, Naylor A, Scopes DI, Hayes AG.
    Br J Pharmacol; 1992 Aug 01; 106(4):783-9. PubMed ID: 1327387
    [Abstract] [Full Text] [Related]

  • 38. Intrathecal atipamezole augments the antinociceptive effect of morphine in rats.
    Lilius TO, Rauhala PV, Kambur O, Rossi SM, Väänänen AJ, Kalso EA.
    Anesth Analg; 2012 Jun 01; 114(6):1353-8. PubMed ID: 22556211
    [Abstract] [Full Text] [Related]

  • 39. Evaluation of selective NK(1) receptor antagonist CI-1021 in animal models of inflammatory and neuropathic pain.
    Gonzalez MI, Field MJ, Hughes J, Singh L.
    J Pharmacol Exp Ther; 2000 Aug 01; 294(2):444-50. PubMed ID: 10900217
    [Abstract] [Full Text] [Related]

  • 40. Concurrent bullatine A enhances morphine antinociception and inhibits morphine antinociceptive tolerance by indirect activation of spinal κ-opioid receptors.
    Huang Q, Sun ML, Chen Y, Li XY, Wang YX.
    J Ethnopharmacol; 2017 Jan 20; 196():151-159. PubMed ID: 27989510
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.